glp-1 and ckd Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney heart protection Study uncovers how chronic kidney

The weight loss platform Noom recently launched its compounded GLP-1 microdose injections that claim to promote weight loss with fewer side effects.

SCFAs mediate systemic antioxidant responses via gut-organ axis communication, while EVs ameliorate intestinal barrier dysfunction through MAPK signaling pathway modulation

net prices to those in Australia, Canada, France, and others

Learn about tirzepatide's FDA-approved uses, potential anti-inflammatory effects, safety considerations, and evidence-based treatments for autoimmune conditions.

Automatic Coupons (Amazon Pharmacy) are embedding savings directly at checkout, no searching required

GLP-1 drugs are remarkably effective at reducing visceral fat, which accumulates around the waist, surrounding and invading the liver, heart, and pancreas